Late-Breaking Clinical Trials and First Report Investigations
Submission Opens: NOW OPEN
Submission Deadline: August 22, 2016 2PM EDT (GMT/UTC -04:00)
Late-Breaking Clinical Trials are typically first-time international or US presentations of the primary endpoint or important secondary endpoint results of prospective randomized clinical trials or of large-scale, impactful single-center or multicenter registries. Accepted Late-Breaking Clinical Trial submissions will be presented in the Main Arena at TCT 2016 and during press conferences scheduled on the same days as the Main Arena presentations. First Report investigations are typically early experiences with novel devices or drugs. The following rarely qualify as Late-Breaking Clinical Trial (or even First Report Investigation) submissions: pre-clinical studies, early first-in-human device studies, and meta-analyses; these should be submitted as Abstracts or as Interventional Innovations. When in doubt, please contact Margaret Zetts at the following email address: firstname.lastname@example.org.